InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Theravance Biopharma, Inc.

TBPH Clue Score61
United States Fiscal year ends December CIK 0001583107 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Rhonda Farnum
15 Sep 2026
SVP, Comm & Medical Affairs
Sold on a plan
6,657
$17.03
$113.40K
Rhonda Farnum
15 Sep 2026
SVP, Comm & Medical Affairs
Sold on a plan
3,328
$17.03
$56.69K
Rhonda Farnum
15 Sep 2026
SVP, Comm & Medical Affairs
Sold on a plan
3,329
$17.03
$56.71K
Rhonda Farnum
15 Jun 2026
SVP, Comm & Medical Affairs
Sold on a plan
6,657
$16.39
$109.08K
Rhonda Farnum
15 Jun 2026
SVP, Comm & Medical Affairs
Sold on a plan
3,328
$16.38
$54.53K
Rhonda Farnum
15 Jun 2026
SVP, Comm & Medical Affairs
Sold on a plan
3,329
$16.39
$54.56K
Rhonda Farnum
16 Mar 2026
SVP, Comm & Medical Affairs
Sold on a plan
7,766
$13.92
$108.07K
Rhonda Farnum
16 Mar 2026
SVP, Comm & Medical Affairs
Sold on a plan
15,534
$14.00
$217.48K
Rhonda Farnum
16 Mar 2026
SVP, Comm & Medical Affairs
Sold on a plan
7,767
$13.92
$108.09K
Rhonda Farnum
3 Dec 2025
SVP, Comm & Medical Affairs
Sold on a plan
15,534
$18.75
$291.25K
Rhonda Farnum
3 Dec 2025
SVP, Comm & Medical Affairs
Sold on a plan
7,766
$18.75
$145.62K
Rhonda Farnum
3 Dec 2025
SVP, Comm & Medical Affairs
Sold on a plan
7,767
$18.75
$145.63K
Show all 20 transactions →

What was left out

Form 4 filings counted 48
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 1
Joint filings 1
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 5
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 11,243,182
History held since 19 May 2014